Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Smeland, Sigbjørn, Bielack, Stefan S., Whelan, Jeremy, Bernstein, Mark, Hogendoorn, Pancras, Krailo, Mark D., Gorlick, Richard, Janeway, Katherine A. +44 more·2019·European Journal of Cancer

Cited by (720)

Items 601–700 of 720

  1. Staging for Childhood Cancer Management
    Ata Ur Rehman Maaz, Mehak Raja, Humayun Bashir · 2025 · Springer eBooks
  2. Improving outcomes in paediatric high-grade osteosarcoma: Insights from a retrospective survival study
    Sachin Kanwar, Mohit Dhingra, Vishal Reddy Duddukunta, Siddhartha Sunil Singh, Sai Prasath · 2025 · Journal of Clinical Orthopaedics and Trauma
  3. Silent Persistence: Genomic Characterization of Late Pulmonary Relapse in Osteosarcoma After a Decade of Remission
    Oz Mordechai, Anat Ilivitzki, Eugene Vlodavsky, Myriam Weyl Ben Arush, Sergey Postovsky · 2025 · Pediatric Blood & Cancer
  4. Dramatic multifocal osteosarcoma treatment response in the setting of POT1 tumor predisposition syndrome
    Stephen Gilene, Kristen D'Aquila, Brittany Elle Cooper, Sara Szabo, Joseph Gerald Pressey · 2025 · Cancer Genetics
  5. Enhancing the Effectiveness of Chemotherapy in Osteosarcoma by Targeting Tumour‐Associated Macrophages (TAMs) through STING Activation
    Jordan C. O'Donoghue, Amanda Guitián‐Caamaño, Maeve Boyce, Fiona E. Freeman · 2025 · Advanced Therapeutics
  6. Mevalonate pathway activation in Ewing sarcoma reveals a 3D-specific synergy between statins and BCL-xL inhibition
    Branka Radic-Sarikas, Marica Marković, Martha Magdalena Zylka, Caterina Sturtzel, Mathias Ilg, Didier Surdez, Martin Lothar Metzelder, Martin Distel, Aleksandr Ovsianikov, Florian Halbritter et al. · 2026 · Molecular Therapy Oncology
  7. Creatine Kinase Blockade Disrupts Energy Metabolism and Redox Homeostasis to Suppress Osteosarcoma Progression
    Shingo Kishi, Rika Sasaki, Rina Fujiwara‐Tani, Hitoshi Ohmori, Yi Luo, Kiyomu Fujii, Takamitsu Sasaki, Kei Goto, Yoshihiro Miyagawa, Isao Kawahara et al. · 2025 · International Journal of Molecular Sciences
  8. Physis-sparing rotationplasty as a salvage procedure after failed allograft in paediatric osteosarcoma
    Devika A Shenoy, Katelyn Parsons, Aaron D Therien, Isabel P. Prado, Grant H. Cabell, Julia D. Visgauss, William C. Eward · 2025 · BMJ Case Reports
  9. Creatine kinase B, a downstream effector of c-Myb, controls migration of osteosarcoma cells via regulation of N-cadherin
    Jana Pokludová, Petr Lapčík, Iva Staniczková Zambo, Jiří Kohoutek, Danica Zapletalová, Peter Múdrý, Dagmar Adámková, Jakub Červinka, Tomáš Loja, Matej Lexa et al. · 2025 · Cancer Cell International
  10. VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol
    Juliana Salazar, Maria Jesús Arranz, Javier Martín‐Broto, Massimo Serra, Emanuela Palmerini, Jerónimo Martínez, Antonio Juan Ribelles, Maitane Andión Catalán, Javier Martínez‐Trufero, Guiomar Gutiérrez et al. · 2025 · Pharmaceuticals
  11. Metastatic Pulmonary Artery Thromboembolism from Osteosarcoma of the Femur
    Anitha Mandava, Meghana Kandati, Rakesh Juluri, Veeraiah Koppula · 2025 · Radiology Cardiothoracic Imaging
  12. Methotrexate in the treatment of osteosarcoma in children and adolescents: the experience of the musculoskeletal sarcoma research group of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
    Elena I. Konopleva, A. I. Karachunskiy, Олег Иванович Быданов, Galina A. Novichkova · 2025 · Pediatric Hematology/Oncology and Immunopathology
  13. Metastatic osteosarcoma to the squamous temporal bone with intra- and extracranial extension: A case report
    Connor A. Sierra, Fareed Jumah, Ravi S. Nunna, Balint Otvos, Arnaldo L. Rivera, Andrew Youkilis · 2025 · Surgical Neurology International
  14. Various Expression and Clinical Significance of Checkpoint Molecules in Advanced Osteosarcoma: Possibilities for Novel Immunotherapy
    Lu Xie, Chenglong Chen, Xin Liang, Jie Xu, Xin Sun, Kunkun Sun, Rongli Yang, Xiaodong Tang, Wei Guo · 2021 · Research Square
  15. Additional file 1 of The effects of MEX3A knockdown on proliferation, apoptosis and migration of osteosarcoma cells
    Bangmin Wang, Hong, Zheping, Zhao, Chen, Bi, Qing, Yuan, Junhui, Chen, Jihang, Shen, Yi · 2021 · Figshare
  16. Additional file 1 of Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review
    Evelien G. E. Hurkmans, Annouk C. A. M. Brand, Job A.J. Verdonschot, te Loo, D. Maroeska W. M., Marieke J. H. Coenen · 2023 · Figshare
  17. Additional file 11 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Yan Zhang, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  18. Additional file 21 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  19. Additional file 2 of Cross-cultural adaptation and validation of a self-reporting tool to assess health-related quality of life for Egyptians with extremity bone sarcomas in childhood or adolescence
    Nesma Farid, Chun, Sungsoo, Omneya Hassanain, Salama, Mohamed, Elham Esam, Fatima Adel, Ismail Rashad, Ahmed Mohamed El Ghoneimy · 2024 · Figshare
  20. Additional file 2 of Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China
    Zhang, Chao, Haixiao Wu, Xu, Guijun, Xu, Yao, Ma, Wenjuan, Li, Zhijun, Zhang, Jin · 2023 · Figshare
  21. Additional file 11 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  22. Additional file 7 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Yan Zhang, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  23. Additional file 3 of Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China
    Zhang, Chao, Haixiao Wu, Xu, Guijun, Xu, Yao, Ma, Wenjuan, Li, Zhijun, Zhang, Jin · 2023 · Figshare
  24. Additional file 6 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Yan Zhang, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  25. Additional file 6 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  26. Additional file 2 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Yan Zhang, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  27. Additional file 8 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Ziyao Li, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  28. Additional file 1 of Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China
    Zhang, Chao, Haixiao Wu, Xu, Guijun, Xu, Yao, Ma, Wenjuan, Li, Zhijun, Zhang, Jin · 2023 · Figshare
  29. Additional file 5 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Ziyao Li, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  30. Additional file 17 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Ziyao Li, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  31. Additional file 4 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Yan Zhang, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  32. Additional file 2 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  33. Additional file 4 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Ziyao Li, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  34. Additional file 9 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  35. Additional file 16 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  36. Additional file 7 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  37. Additional file 4 of Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
    Wang, Jun, Hongliang Zhang, Sun, Xin, Wang, Xiaofang, Tingting Ren, Huang, Yi, Zhang, Ranxin, Zheng, Bingxin, Wei Guo · 2020 · Figshare
  38. Additional file 1 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Yan Zhang, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  39. Additional file 2 of Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
    Wang, Jun, Hongliang Zhang, Sun, Xin, Wang, Xiaofang, Tingting Ren, Huang, Yi, Zhang, Ranxin, Zheng, Bingxin, Guo, Wei · 2020 · Figshare
  40. Additional file 1 of Complete remission of metastatic osteosarcoma using combined modality therapy: a retrospective analysis of unselected patients in China
    Xie, Lu, Xu, Jie, Li, Xiaowei, Zhou, Zuli, 庄洪卿, Sun, Xin, Liu, Kuisheng, Liu, Xingyu, Sun, Kunkun, Wu, Yiming et al. · 2021 · Figshare
  41. Additional file 13 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  42. Additional file 9 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Yan Zhang, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  43. Additional file 3 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Zhang, Yan, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  44. Additional file 10 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Ziyao Li, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  45. Additional file 3 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  46. Soft Tissue and Bone Tumors of the Head and Neck
    Henryk A. Domanski, Paweł Gajdzis · 2024 · Springer eBooks
  47. Additional file 1 of A tumor microenvironment-based prognostic index for osteosarcoma
    Changwu Wu, Siming Gong, Yingjuan Duan, Deng, Chao, Sonja Kallendrusch, Laura Katharina Berninghausen, Georg Osterhoff, Nikolas Schopow · 2023 · Figshare
  48. Additional file 14 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  49. Additional file 5 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Yan Zhang, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  50. Additional file 2 of Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review
    Evelien G. E. Hurkmans, Annouk C. A. M. Brand, Job A.J. Verdonschot, te Loo, D. Maroeska W. M., Marieke J. H. Coenen · 2023 · Figshare
  51. Additional file 1 of Cross-cultural adaptation and validation of a self-reporting tool to assess health-related quality of life for Egyptians with extremity bone sarcomas in childhood or adolescence
    Nesma Farid, Chun, Sungsoo, Omneya Hassanain, Salama, Mohamed, Elham Esam, Fatima Adel, Ismail Rashad, Ahmed Mohamed El Ghoneimy · 2024 · Figshare
  52. Additional file 22 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  53. Additional file 12 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Ziyao Li, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  54. Additional file 15 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  55. Additional file 3 of Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
    Wang, Jun, Hongliang Zhang, Sun, Xin, Wang, Xiaofang, Tingting Ren, Yi Huang, Zhang, Ranxin, Zheng, Bingxin, Wei Guo · 2020 · Figshare
  56. Additional file 2 of Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
    Hong, Weifeng, Yuan, Hong, Gu, Yujun, Mouyuan Liu, Yayun Ji, Huang, Zifang, Yang, Junlin, Ma, Liheng · 2020 · Figshare
  57. Additional file 10 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Yan Zhang, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  58. Additional file 19 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  59. Additional file 8 of Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
    Liu, Yongheng, Li, Guanghao, Yan Zhang, Li, Lili, Zhang, Yanting, Huang, Xiaoyu, Wei, Xianfu, Zhou, Peng, Ming Liu, zhao, Gang et al. · 2022 · Figshare
  60. Additional file 1 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  61. Additional file 20 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  62. Additional file 18 of ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
    Xin, Shiyong, Liu, Xiang, Li, Ziyao, Sun, Xianchao, Wang, Rong, Zhang, Zhenhua, Feng, Xinwei, Jin, Liang, Li, Weiyi, Chaozhi Tang et al. · 2024 · Figshare
  63. Epigenetic patterns and methylation-based models for robust outcome prediction in osteosarcoma
    Joshua J. Bowers, Nikhil Ramavenkat, Christopher E. Lietz, Miya Hugaboom, Aditya Madupur, Edwin Choy, Gregory Michael Cote, Hang Lee, Martin J. Aryee, Dimitrios Spentzos · 2025 · medRxiv
  64. Tumor‐Infiltrating Lymphocyte Adoptive Cell Therapy With PD‐1 Blockade in Pediatric Chemotherapy‐Resistant Osteosarcoma
    Helen Thut, Reto Ritschard, Katharina Glatz, Raphael Nicolas Vuille-dit-Bille, Maya Caroline Andre, Stephanie J. Gros, Severin Kasser, Andreas H. Krieg, Renata Rosa Pereira, Fatime Krasniqi et al. · 2025 · Pediatric Blood & Cancer
  65. Reassessing the 8 cm Cutoff: Continuous Tumor Size‐Mortality Risk Supports Three‐Tier Staging in High Grade Osteosarcoma
    Ezekiel Dingle, Kole Joachim, Othneil Noble Sparks, Adrian J. Lin, Brandon S. Gettleman, Christopher David Hamad, Casey Abernethy, Michael P. Fice, Nicholas Matthew Bernthal, Alexander B. Christ · 2025 · Journal of Surgical Oncology
  66. Delayed Aggressive Local Recurrence of Chondroblastic Osteosarcoma 3 Years After an Excellent Pathological Response: A Case Report
    Abdul Hannan, Bilal Aslam, Natasha Elaine Hastings, Deepa Lachhman Das, Zahra Sania, Marium Mansoor, Fazeela Bibi, Khalil ELABDI, Samreen Najeeb, Kristen Batten et al. · 2026 · Clinical Case Reports
  67. Age-dependent chromosomal instability in osteosarcoma: younger patients exhibit paradoxically higher genomic damage
    Tiara S. Jamison · 2026 · Research Square
  68. Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric Analysis
    Jenna Kocsis, Shauna R. Campbell, Jonathan Jang, Eashwar V. Somasundaram, Chandana A. Reddy, Jacob G. Scott, Lilyana Angelov, Peter Meade Anderson, Matteo M. Trucco, Zachary D. C. Burke et al. · 2026 · Pediatric Blood & Cancer
  69. Characterizing two subtypes of osteosarcoma using G2M checkpoint-related genes and revealing its immune landscape
    Zhuobin Yang, Hong Song · 2026 · Molecular Immunology
  70. Efficacy analysis and survival prediction of unique chemotherapy regimens for osteosarcoma in China
    Ruizhen Wang, Zhen Bao, Fengrong Chen, Fei Gao, Jing Yang, Wei Wang · 2026 · Frontiers in Physiology
  71. Five Year Survival of Common Primary Bone Cancers in Guilan, The North Province of Iran, 2014 - 2018: A Retrospective Cohort Study
    Leila Kanafi Vahed, Shafa Rahiminia, Zahra Atrkar Roushan, Afshin Aryanpour, Gholamreza Sadeghi · 2026 · International Journal of Cancer Management
  72. Clarification on the interpretation of TCGA-SARC data in the prognostic evaluation of MMP13 in osteosarcoma
    Jiro Ichikawa, Masanori Wako, Tomonori Kawasaki · 2026 · Toxicology and Applied Pharmacology
  73. High-grade surface Osteosarcoma – Data from the Cooperative Osteosarcoma Study Group (COSS)
    Patricia J. Schäfenacker, Stefanie Hecker‐Nolting, Stefan Bielack, Matthias Kevric, Benjamin Sorg, Arndt Borkhardt, Bernd Hertenstein, Peter Reichardt, Daniel A. Müller, Leo Kager et al. · 2026 · Pediatric Hematology Oncology Journal
  74. Beyond growing pains: recognizing bone tumours in childhood and adolescence
    Alexandra Norman, Vicki Lee · 2026 · Paediatrics and Child Health
  75. Aptamers in Osteosarcoma: New Paths for Diagnosis and Treatment
    Guy Awad, Marc Boutros, Antoine Chartouni, Juan Pretell-Mazzini · 2026 · Anti-Cancer Agents in Medicinal Chemistry
  76. Sociodemographics and Attrition in Children With Osteosarcoma Enrolled in the AOST0331 Clinical Trial
    Daniel J. Zheng, Natalie J. DelRocco, Ruxu Han, Mark Krailo, Rahela Aziz‐Bose, Kristine A. Karvonen, Colleen A. Kelly, Haley M. Newman, Puja J. Umaretiya, Lenka Anne Skaidrite Ilcisin et al. · 2026 · JAMA Network Open
  77. Impact du microenvironnement et de la vascularisation tumorale dans la réponse de l’ostéosarcome à la chimiothérapie
    Vincent Crenn · 2021 · theses.fr (ABES)
  78. Liquid Biopsy in Pediatric Sarcoma
    Samuel D. Abbou · 2022
  79. Histotripsy treatment reduces tumor burden and extends survival in an orthotopic mouse model of osteosarcoma
    Elliana Vickers, Alayna N. Hay, Víctor A. López, Lauren N. Ruger, Ny T. C. Luong, Julianna M. Diodato, Triniti Antony Baskar, Alyssa Sze, Maosen Wang, Steven B. Soliman et al. · 2026 · Frontiers in Oncology
  80. Construction and validation of a multimodal MRI-based quantitative feature prediction model for the prognosis of non-metastatic primary osteosarcoma
    Chao Xu, Chengcun Huo, Longjiang Wang · 2026 · Frontiers in Oncology
  81. Ostéosarcomes
    Philippe Anract, Fréderique Larousserie, Marie Desportes, Camille Tlemsani · 2026 · EMC - Appareil locomoteur
  82. Evaluation of ChatGPT’s responses to frequently asked questions from osteosarcoma patients: A descriptive cross-sectional study
    Savaş Yildirim, Mert Çiftdemir, Murat Erem, Eşref Selçuk, Onat Salih · 2026 · Medicine
  83. Long-Term Kidney Outcomes in Paediatric Osteosarcoma Survivors: A 20-Year Multi-Centre Study
    Christy Mak, Dennis T. L. Ku, Anthony P. Y. Liu, Vincent Lee, Jeffrey P W Yau, Eric Chun-Ho Fu, Evelyn Ruoyun Lu, Matthew M. K. Shing, Irene Yuk-Ying Ho, Will WL Pak et al. · 2026 · Cancers
  84. Multi-modal therapeutic action of gallium-containing bioactive glass against osteosarcoma and bacterial pathogens
    Lucas Pereira Lopes de Souza, João Henrique Lopes, Luis Felipe Moreira Oliveira, Farah N. S. Raja, Archana Singh, Shirin B. Hanaei, Darrell Green, Adrian Gardner, Jonathan Daniel Stevenson, Richard Alan Martin · 2026 · Engineered Regeneration
  85. Pediatric Bone Sarcomas: A Single-Center Experience in Jordan
    Mais Jazazi, Mousa Qatawneh, Ayman Alhwayan, Hanadi Alkhalaileh, Shatha Alqaisi, Firas Hussein Alsmadi, Eman Alquraan, Mohammad Alhawamdeh, Dima Alhamad, Maher Khader · 2026 · Cureus
  86. Paget's Disease of the Spine as a Catalyst for Osteosarcoma: A Narrative Review
    Gonzalo F. Del Rio Montesinos, Kevin Yoon, Amanuel Ayano, Linus Lee, Mark Ehioghae, Jonathan P. Japa, Lancelot Benn, Addisu Mesfin · 2026 · Cureus
  87. Single‐Cell Transcriptomic Analysis Suggests That JUN May Regulate BAMBI to Promote Osteosarcoma Cell Migration and Invasion
    Ning Song, Zhang Qiang, Junwei Du, Renbing Jiang · 2026 · Human Mutation
  88. Current Practice of High-Dose Methotrexate Use in Osteosarcoma Patients at Vinmec Times City Hospital
    Nguyen Tu Son, Nguyen Thi Hoai Ly, Nguyen Manh Thang, Phan Quỳnh Lan, Nguyen Le Trang, Nguyen Quynh Bao Ngoc, Trần Thị Thu Trang · 2026 · VNU Journal of Science Medical and Pharmaceutical Sciences
  89. METTL14‐Mediated RPL13A Expression Regulates Apoptosis and Invasion of Osteosarcoma via the PTEN/PI3K/AKT Signaling Pathway
    Zilong Chen, Yanqi Pan, Yuhang Wei, Yanxiang Tong, Yaguang Li, Guozhong Zhao, Fei Xue, Yu Zhao, Chenyang Meng, Wei Feng · 2026 · Journal of Orthopaedic Research®
  90. Performance and pilot clinical validation of MALDITEC-CTC: a circulating tumor cell detection platform using whole-cell MALDI-TOF MS fingerprinting in osteosarcoma
    Santhasiri Orrapin, Nutnicha Sirikaew, Wararat Chiangjong, Somchai Chutipongtanate, Pimpisa Teeyakasem, Sasimol Udomruk, Sutpirat Moonmuang, Songphon Sutthitthasakul, Petlada Yongpitakwattana, Areerak Phanphaisarn et al. · 2026 · Cancer Cell International
  91. Transcriptome-Inferred metabolic subtypes define prognostic and immune ecosystems in osteosarcoma at single-cell resolution
    Li Hu, Dingsheng Zhang, Boyang Wang, Qian Liu, Xingyu Liao, Feiyang Qi, Linxi Chen, Huimin Liu, Zhiqing Zhao, Haijie Liang et al. · 2026 · Frontiers in Pediatrics
  92. Synthesis of Gd-DOTA-BMTP and its application in gadolinium neutron capture therapy for osteosarcoma
    Aoyun Yan, Liming Zhu, Bowen Luo, Xiaoxi Pang, Jialin Qin, Liang Dong, Yufei Zhao, Ni Chen · 2026 · Journal of Cancer Research and Clinical Oncology
  93. Cutaneous Metastases from Bone Sarcomas
    Nikolaos Sideris · 2026 · Springer eBooks
  94. Contralateral lower-limb growth after systemic chemotherapy and surgery for high-grade osteosarcoma in children: a retrospective longitudinal MRI study
    Y Tian, Kuan‐Lin Chen, Kevin Chi-Yun Kao, Pai-Han Wang, Chao-Ming Chen, Yu-Kuan Lin, Shang-Wen Tsai, Po‐Kuei Wu, C Chen, Wei‐Ming Chen · 2026 · Journal of Orthopaedic Surgery and Research
  95. Mn-augmented CuFe-layered double hydroxide nanozymes orchestrate multimodal cell death to reshape the osteosarcoma innate immune activation landscape
    Zhaojie Wang, Jiabao Cai, Yixi Wang, Jiani Fan, Juechen Lu, Yuchen Ke, Chi Liang, Shengguang Chen · 2026 · Chemical Engineering Journal
  96. Evaluation of Nuclear Factor of Activated T-cells (NFATc1) Expression in Non-metastatic Osteosarcoma Tissue
    2026 · Medicine & health
  97. Reducing complications after resection of pelvic bone sarcomas
    Lee Marcus Jeys, Vineet John Kurisunkal, Michael Parry, Guy Morris, Jonathan Daniel Stevenson, Minna Laitinen · 2026 · The Bone & Joint Journal
  98. Long-term Results of Multiantigen Stimulated Cell Therapy I, Alone or in Combination with Chemotherapy, as First-line Maintenance Therapy in Advanced Sarcoma: A Multicenter, Phase I Trial
    Xing Zhang, Bu-Shu Xu, Qiuzhong Pan, Ruiqing Peng, Desheng Weng, Jingjing Zhao, Xizhi Wen, Qiyan Cai, Wei Li, Hongcheng Hu et al. · 2026 · Clinical Cancer Research
  99. Pediatric sarcomas: challenges and opportunities
    Yuan Gao, Kelly M. Bailey, Samuel C. Blackman, John Hackett Bushweller, Shasha Chong, Kevin DeHond, Jolanta E. Grembecka, Mark E. Hatley, Cigall Kadoch, Angela N. Koehler et al. · 2026 · Genes & Development
  100. Pathologic response to neoadjuvant therapy in high-grade osteosarcoma: A high-volume centre versus community centre analysis
    Ming Zeng, HuiLin Yang · 2026 · Radiation Physics and Chemistry